Eurobio announced the attainment of European and American patents for its i-Glide device for the handling and storage of corneal lamellar grafts. The patents are co-owned with the Venice Eye-Bank (FBOV), according to a company news release.
"These two patents result from a strategic partnership between Eurobio and the FBOV. We are glad and proud to concretize this new offer for a device aimed towards handling and storage of corneal lamellar grafts," Denis Fortier, general manager of Eurobio, said in the news release. "This device also enables us to enhance our commercial offer for the American market."
Eurobio holds the exclusive global marketing for the i-Glide.
The i-GLIDE device:
I-Glide brings forward an innovative solution for the preservation and specific transport of the corneal endothelium, making the DSAEK easier, quicker, and more flexible.
Corneal trephination and precutting are performed in the eye bank. The lamellar membrane is inserted in the i-Glide device, which is filled with a proper storage medium (such as CORNEA Cold) and sent to the operating room. The endothelium can then be preserved in its storage medium for up to a week.
The i-GLIDE device saves time and ensures an optimal reproducibility during the surgical procedure. Thanks to its technical simplicity, the learning curve is reduced to a minimum for the surgeons.